A federal watchdog group said HHS isn't doing enough to measure how much patients use their medical records.
Thomas Meade, serial entrepreneur, is on to his fourth venture, Ohmx, a 20-employee company in Evanston, Illinois, that is developing electronic handheld devices to detect proteins such as those generated from heart attacks
How health systems must better prepare and take action to avoid the costly problem of retained surgical items (RSI's).
Complications from warfarin can be serious. According to one study published in 2011, it is implicated in 33% of adverse drug events in patients 65 or older, and nearly all of those events are from unintentional overdoses.
The role of 3-D printing in transforming the practice of radiology will be highlighted during the Radiological Society of North America's annual meeting in Chicago, which runs through Dec. 1.
Hostilities are intensifying in the misbegotten matchup of Abbott Laboratories and Alere. The two medical products companies haven't stopped fighting since shortly after Abbott agreed in January to buy Alere for $5.8 billion.
A serious commitment to “doubling the pace” of progress will require the public and private sectors to consider doubling investments in medical research to about $1,000 per American per year to find the solutions to what ails us.
Despite the slew of new partnerships and initiatives, efforts to accelerate cancer research still face obstacles on several fronts, the vice president said in a report Monday.
Detroit's Henry Ford Health System has been selected as one of several provider organizations to receive a share of a five-year, $5.5 million federal grant to lead data collection on a project that is part of the human genome research and precision medicine program.
Embattled blood testing company Theranos says it will shut down its clinical labs and wellness centers and lay off more than 40% of its full-time employees.
Now 55 cases filed in California against the pharmaceutical company Bayer can proceed before a single judge.
Abbott waffled on its commitment to purchase Alere in April because of concerns about the accuracy of Alere's statements and representations in the agreement. The North Chicago, Ill., company this month warned that it may not go through with the proposal.